ENHANCEMENT OF HUMAN CALCITONIN ABSORPTION ACROSS THE RAT COLON IN-VIVO

被引:27
作者
HASTEWELL, J
LYNCH, S
FOX, R
WILLIAMSON, I
SKELTONSTROUD, P
MACKAY, M
机构
[1] CIBA GEIGY PHARMACEUT CORP, DRUG PREFORMULAT & DELIVERY, HORSHAM RH12 4AB, W SUSSEX, ENGLAND
[2] CIBA GEIGY PHARMACEUT CORP, PRECLIN SAFETY, MORLEY SK9 4LY, W YORKSHIRE, ENGLAND
关键词
HUMAN CALCITONIN; ABSORPTION ENHANCER; ORAL DRUG DELIVERY; COLON; HYPOCALCEMIC RESPONSE; MIXED MICELLES;
D O I
10.1016/0378-5173(94)90082-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have studied the influence of equimolar monoolein: sodium taurocholate enhancer formulations on the absorption of human calcitonin (hCT) and two markers of intestinal permeability, horseradish peroxidase (HRP) and polyethylene glycol, molecular weight 4000 (PEG 4000). hCT, HRP and PEG 4000 were air absorbed across the colonic mucosa to a limited extent. The use of 40 mM monoolein:40 mM sodium taurocholate significantly (p < 0.001) enhanced (9.0 +/- 1.0-fold) the absorption of all three molecules with no damage to the mucosal tissue at the light microscopy level At concentrations of 20 mM and below, the monoolein:sodium taurocholate formulation did not enhance the absorption of hCT. HRP immunohistochemistry showed an intracellular localisation suggesting that the transcellular pathway was involved in the absorption process; The increased absorption of hCT in the presence of the 40 mM enhancer formulation was able to elicit a maximal hypocalcaemic response, whereas no significant effect was observed in the absence of the enhancer. We conclude that the absorption enhancer used in this study, can increase intestinal absorption of a range of molecules without causing major tissue damage. Such formulations may offer advantages as they enable pharmacodynamic responses to be elicited from smaller doses of therapeutic peptides and proteins.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 27 条
[1]   AN IMMUNOSPECIFIC ENZYME ASSAY FOR HORSERADISH-PEROXIDASE [J].
AMBLER, L ;
PETERS, GE .
ANALYTICAL BIOCHEMISTRY, 1984, 137 (01) :66-68
[2]   COLONIC ABSORPTION OF HUMAN CALCITONIN IN MAN [J].
ANTONIN, KH ;
SAANO, V ;
BIECK, P ;
HASTEWELL, J ;
FOX, R ;
LOWE, P ;
MACKAY, M .
CLINICAL SCIENCE, 1992, 83 (05) :627-631
[3]   CALCITONIN - PHYSIOLOGY AND PATHO-PHYSIOLOGY [J].
AUSTIN, LA ;
HEATH, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (05) :269-278
[4]   INTRACOLONIC BIOAVAILABILITY OF HUMAN CALCITONIN IN MAN [J].
BEGLINGER, C ;
BORN, W ;
MUFF, R ;
DREWE, J ;
DREYFUSS, JL ;
BOCK, A ;
MACKAY, M ;
FISCHER, JA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (05) :527-531
[5]   COMBINATIVE PROMOTION EFFECT OF AZONE AND FUSOGENIC FATTY-ACID ON THE LARGE INTESTINAL-ABSORPTION IN RAT [J].
FUKUI, H ;
MURAKAMI, M ;
TAKADA, K ;
MURANISHI, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 31 (03) :239-246
[6]  
GALLATI H, 1985, J CLIN CHEM CLIN BIO, V23, P453
[7]   NEW FORMS OF INSULIN [J].
GALLOWAY, JA ;
ROOT, MA .
DIABETES, 1972, 21 :637-&
[8]  
GENNARI C, 1983, LANCET, V1, P594
[9]   TREATMENT OF PAGETS-DISEASE OF BONE WITH SYNTHETIC HUMAN CALCITONIN - BIOCHEMICAL AND ROENTGENOLOGIC CHANGES [J].
GREENBERG, PB ;
DOYLE, FH ;
FISHER, MT ;
HILLYARD, CJ ;
JOPLIN, GF ;
PENNOCK, J ;
MACINTYRE, I .
AMERICAN JOURNAL OF MEDICINE, 1974, 56 (06) :867-870
[10]   ABSORPTION OF HUMAN CALCITONIN ACROSS THE RAT COLON INVIVO [J].
HASTEWELL, J ;
LYNCH, S ;
WILLIAMSON, I ;
FOX, R ;
MACKAY, M .
CLINICAL SCIENCE, 1992, 82 (05) :589-594